Abbott Laboratories
ABT · New York Stock Exchange · Health Care
☆ Follow
Shareholder advocacy aimed at Abbott Laboratories
Nothing recorded yet. That means no campaign in our database names this company, not that none exists.
What shareholders voted on
From Abbott Laboratories’s own filings with the SEC. Support is the share of votes cast for and against, so abstentions and broker non-votes are not counted in it.
2026
| Item | Kind | Asked for by | Support | Outcome |
|---|---|---|---|---|
| Election of Claire Babineaux-Fontenot | Director | 99.8% | Passed | |
| Election of Nita Ahuja | Director | 99.8% | Passed | |
| Election of Darren W. McDew | Director | 99.5% | Passed | |
| Election of Paola Gonzalez | Director | 99.5% | Passed | |
| Election of Michelle A. Kumbier | Director | 99.2% | Passed | |
| Election of Sally E. Blount | Director | 98.8% | Passed | |
| Election of Michael F. Roman | Director | 98.6% | Passed | |
| Election of John G. Stratton | Director | 98% | Passed | |
| Election of Michael G. O’Grady | Director | 97.6% | Passed | |
| Election of Daniel J. Starks | Director | 95.1% | Passed | |
| Election of Nancy McKinstry | Director | 95% | Passed | |
| Election of Robert B. Ford | Director | 94.6% | Passed |
2025
| Item | Kind | Asked for by | Support | Outcome |
|---|---|---|---|---|
| Sally E. Blount, Ph.D | Company proposal | 98.3% | Passed | |
| Robert J. Alpern, M.D | Company proposal | 97.6% | Passed | |
| Election of Paola Gonzalez | Director | 99.6% | Passed | |
| Election of Claire Babineaux-Fontenot | Director | 99.5% | Passed | |
| Election of Darren W. McDew | Director | 99.4% | Passed | |
| Election of Michelle A. Kumbier | Director | 99.3% | Passed | |
| Election of Michael F. Roman | Director | 98.8% | Passed | |
| Election of Michael G. O’Grady | Director | 98% | Passed | |
| Election of Daniel J. Starks | Director | 96% | Passed | |
| Election of Robert B. Ford | Director | 93.2% | Passed | |
| Election of John G. Stratton | Director | 87.3% | Passed | |
| Election of Nancy McKinstry | Director | 82.1% | Passed |
2024
| Item | Kind | Asked for by | Support | Outcome |
|---|---|---|---|---|
| Sally E. Blount, Ph.D | Company proposal | 97.6% | Passed | |
| Robert J. Alpern, M.D | Company proposal | 96.7% | Passed | |
| Election of Claire Babineaux-Fontenot | Director | 99.3% | Passed | |
| Election of Paola Gonzalez | Director | 99% | Passed | |
| Election of Michelle A. Kumbier | Director | 98.8% | Passed | |
| Election of Darren W. McDew | Director | 98.7% | Passed | |
| Election of Michael G. O’Grady | Director | 98.5% | Passed | |
| Election of Michael F. Roman | Director | 97.6% | Passed | |
| Election of Daniel J. Starks | Director | 97.1% | Passed | |
| Election of Robert B. Ford | Director | 93.3% | Passed | |
| Election of Nancy McKinstry | Director | 82.1% | Passed | |
| Election of John G. Stratton | Director | 74.4% | Passed |
2023
| Item | Kind | Asked for by | Support | Outcome |
|---|---|---|---|---|
| Sally E. Blount, Ph.D | Company proposal | 97.9% | Passed | |
| Robert J. Alpern, M.D | Company proposal | 96.9% | Passed | |
| Election of Michael G. O’Grady | Director | 99.5% | Passed | |
| Election of Claire Babineaux-Fontenot | Director | 99.3% | Passed | |
| Election of Paola Gonzalez | Director | 99% | Passed | |
| Election of Darren W. McDew | Director | 98.8% | Passed | |
| Election of Michelle A. Kumbier | Director | 98.2% | Passed | |
| Election of Daniel J. Starks | Director | 97% | Passed | |
| Election of Robert B. Ford | Director | 92.6% | Passed | |
| Election of Michael F. Roman | Director | 83.9% | Passed | |
| Election of Nancy McKinstry | Director | 75.5% | Passed | |
| Election of John G. Stratton | Director | 72.1% | Passed |
2022
| Item | Kind | Asked for by | Support | Outcome |
|---|---|---|---|---|
| Sally E. Blount, Ph.D | Company proposal | 97.9% | Passed | |
| Robert J. Alpern, M.D | Company proposal | 96.3% | Passed | |
| Election of Paola Gonzalez | Director | 99.6% | Passed | |
| Election of Daniel J. Starks | Director | 99.5% | Passed | |
| Election of Darren W. McDew | Director | 98.8% | Passed | |
| Election of Michelle A. Kumbier | Director | 98.4% | Passed | |
| Election of Michael F. Roman | Director | 97.9% | Passed | |
| Election of Glenn F. Tilton | Director | 95.4% | Passed | |
| Election of Robert B. Ford | Director | 93.7% | Passed | |
| Election of John G. Stratton | Director | 92.4% | Passed | |
| Election of William A. Osborn | Director | 92.1% | Passed | |
| Election of Nancy McKinstry | Director | 76.8% | Passed |
2021
| Item | Kind | Asked for by | Support | Outcome |
|---|---|---|---|---|
| Sally E. Blount, Ph.D | Company proposal | 99.1% | Passed | |
| Robert J. Alpern, M.D | Company proposal | 97.4% | Passed | |
| Election of John G. Stratton | Director | 99.6% | Passed | |
| Election of Darren W. McDew | Director | 99.5% | Passed | |
| Election of Michael F. Roman | Director | 99.1% | Passed | |
| Election of Michelle A. Kumbier | Director | 99% | Passed | |
| Election of Robert B. Ford | Director | 98.5% | Passed | |
| Election of Daniel J. Starks | Director | 97.7% | Passed | |
| Election of Glenn F. Tilton | Director | 94.5% | Passed | |
| Election of Roxanne S. Austin | Director | 93.6% | Passed | |
| Election of Miles D. White | Director | 90.4% | Passed | |
| Election of William A. Osborn | Director | 86.6% | Passed | |
| Election of Nancy McKinstry | Director | 78.1% | Passed |
2020
| Item | Kind | Asked for by | Support | Outcome |
|---|---|---|---|---|
| Sally E. Blount, Ph.D | Company proposal | 99.7% | Passed | |
| Robert J. Alpern, M.D | Company proposal | 98.7% | Passed | |
| Election of John G. Stratton | Director | 99.7% | Passed | |
| Election of Darren W. McDew | Director | 99.6% | Passed | |
| Election of Michelle A. Kumbier | Director | 99% | Passed | |
| Election of Robert B. Ford | Director | 99% | Passed | |
| Election of Daniel J. Starks | Director | 98.8% | Passed | |
| Election of Phebe N. Novakovic | Director | 98.8% | Passed | |
| Election of Edward M. Liddy | Director | 98.2% | Passed | |
| Election of William A. Osborn | Director | 97.5% | Passed | |
| Election of Miles D. White | Director | 97.3% | Passed | |
| Election of Glenn F. Tilton | Director | 95.5% | Passed | |
| Election of Roxanne S. Austin | Director | 94.9% | Passed | |
| Election of Nancy McKinstry | Director | 78.6% | Passed |
2019
| Item | Kind | Asked for by | Support | Outcome |
|---|---|---|---|---|
| Sally E. Blount, Ph.D | Company proposal | 99.5% | Passed | |
| Robert J. Alpern, M.D | Company proposal | 99.3% | Passed | |
| Election of John G. Stratton | Director | 99.5% | Passed | |
| Election of Michelle A. Kumbier | Director | 99.5% | Passed | |
| Election of Daniel J. Starks | Director | 99.1% | Passed | |
| Election of Phebe N. Novakovic | Director | 98.8% | Passed | |
| Election of Edward M. Liddy | Director | 98.1% | Passed | |
| Election of Nancy McKinstry | Director | 97.8% | Passed | |
| Election of Samuel C. Scott III | Director | 97.5% | Passed | |
| Election of William A. Osborn | Director | 97.1% | Passed | |
| Election of Glenn F. Tilton | Director | 95.7% | Passed | |
| Election of Roxanne S. Austin | Director | 95.6% | Passed | |
| Election of Miles D. White | Director | 95.1% | Passed |
2018
| Item | Kind | Asked for by | Support | Outcome |
|---|---|---|---|---|
| Sally E. Blount, Ph.D | Company proposal | 99.1% | Passed | |
| Robert J. Alpern, M.D | Company proposal | 98.6% | Passed | |
| Election of John G. Stratton | Director | 99.3% | Passed | |
| Election of Nancy McKinstry | Director | 99.1% | Passed | |
| Election of Daniel J. Starks | Director | 99% | Passed | |
| Election of Phebe N. Novakovic | Director | 98.1% | Passed | |
| Election of Edward M. Liddy | Director | 97.4% | Passed | |
| Election of Samuel C. Scott III | Director | 96.9% | Passed | |
| Election of William A. Osborn | Director | 96.9% | Passed | |
| Election of Roxanne S. Austin | Director | 95.3% | Passed | |
| Election of Glenn F. Tilton | Director | 95.2% | Passed | |
| Election of Miles D. White | Director | 94.9% | Passed |
Proxy statements and vote results
Straight from Abbott Laboratories’s own SEC filings. The proxy statement lists what shareholders were asked to vote on; the 8-K certifies how the vote went.
| Year | Filing | Filed |
|---|---|---|
| 2026 | Vote results | 2026-04-27 |
| 2026 | Proxy statement | 2026-03-13 |
| 2025 | Vote results | 2025-04-28 |
| 2025 | Proxy statement | 2025-03-14 |
| 2024 | Vote results | 2024-04-29 |
| 2024 | Proxy statement | 2024-03-15 |
| 2023 | Vote results | 2023-05-02 |
| 2023 | Proxy statement | 2023-03-17 |
| 2022 | Vote results | 2022-05-02 |
| 2022 | Proxy statement | 2022-03-18 |
| 2021 | Vote results | 2021-04-26 |
| 2021 | Proxy statement | 2021-03-12 |
| 2020 | Vote results | 2020-04-28 |
| 2020 | Proxy statement | 2020-03-13 |
| 2019 | Vote results | 2019-04-30 |
| 2019 | Proxy statement | 2019-03-15 |
| 2018 | Vote results | 2018-04-30 |
| 2018 | Proxy statement | 2018-03-16 |
Do you represent Abbott Laboratories? Claim this profile to respond to the campaigns listed here.